BioCryst Pharmaceuticals, Inc. (BCRX) Revenue History
BioCryst Pharmaceuticals, Inc. (BCRX) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $26.35M |
| 2017-12-31 | $25.19M |
| 2018-12-31 | $20.65M |
| 2019-12-31 | $48.84M |
| 2020-12-31 | $17.81M |
| 2021-12-31 | $157.17M |
| 2022-12-31 | $270.83M |
| 2023-12-31 | $331.41M |
| 2024-12-31 | $450.71M |
| 2025-12-31 | $874.84M |
How BCRX compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| NEOG | Neogen Corporation | $870.40M |
| VREX | Varex Imaging Corporation | $844.60M |
| ARWR | Arrowhead Pharmaceuticals Inc. | $829.45M |
| MYGN | Myriad Genetics Inc. | $824.50M |
| USPH | U.S. Physical Therapy Inc. | $780.99M |
These are five companies in the same sector as BCRX with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get BioCryst Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("BCRX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BCRX | $9.55 | -1.14% | 2.48M |
| 3 | ||||
| 4 | ||||
| 5 |